The report on Biologics Safety Testing Market by instruments and services (instruments, kits, reagents,
services), test type (endotoxin, adventitious agent detection and residual host contaminant detection tests),
application (tissue-related and blood-related products testing) trends analysis and forecasts up to 2023 studies
the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-
Pacific, Rest of the World. According to the report the Global Biologics Safety Testing Market is projected to
grow at a CAGR between 12.0% and 12.5 % in terms of value over the period of 2017-2023. The growth in the
world market is primarily driven by significant contribution by North America (Leading region) region to this
market.
Get a Sample Request
https://www.infiniumglobalresearch.com/reports/sample_request/708
Market Insights:
The report identified that global biologics safety testing is driven by factors such as number of drug launches
are increased, technological advancements, increase in biotechnology and pharmaceutical industries driven by
government support and regulations. While the restraining factors include high cost of biologics safety testing.
Further, the report identifies the opportunities in the world market as emerging markets offer profitable
growth opportunities, increasing pharmaceutical outsourcing.
Segments Covered
The report on global biologics safety testing market covers the segments based on instruments and services,
test type, and application. The instruments and services of biologics safety testing include instruments, kits &
reagents and services. The test type segment includes bioburden tests, endotoxin tests, adventitious agent
detection tests, cell line authentication and characterization tests, residual host contaminant detection tests,
adventitious agent detection tests and other test. On the basis of application the global biologics safety testing
Infinium Global Research